Not having a Mac and reading the description
I'd say a rebuild is warranted, but for a final decision I want to hear
what Markus has to say. He is familiar with Mac.
David M Williams <david_williams@xxxxxxxxxx>
Regression in Luna SR1, due to "Platform Runtime Binary" regression,
may be worthy of respin
There's been some late-breaking regressions found in EPP packages, which,
at their root, are (partially) due to a regression in Eclipse Platform
Runtime. (no regression with SDK, but even there, it will be effected by
new Apple requirements for signing apps for 10.9.5).
This regression concerns Macs only and is related to the Info.plist file.
Plus, while investigating that, I've discovered there are new signing requirements
for Mac OS X 10.9.5 and higher. While that OS version has only been out
a week or two ... it has been no secret it's changing and we may look pretty
poor if "Eclipse.app" suddenly stops working, after people upgrade
to 10.9.5. (Though, would still work, from command line, which I suspect
is why none of us noticed it, until now).
I have opened a "central" bug to discuss what options we have
for Luna SR1 (Bug
as well as what to do for Mars M2, which has same issues (Bug
I have taken the liberty of starting a maintenance rebuild, which is nearly
done building. And will soon start re-building the Sim. Release repo (where,
only the Eclipse and Equinox contributions will change) ... but can always
"throw them away" depending on if the PMC (or Planning Council)
wants to take some other action. And/or "through them away" and
do all over again, if the webmasters say they can fix the new signing requirements
issue this morning. [The new signing requirements is a pretty sticky issue,
since if I am reading it right, we should actually go "back in time"
and re-sign existing, old releases as well, for them to work on 10.9.5!
-- in other words, a lot of work -- for someone].
I'll be sending a note to Planning Council "in parallel", just
for efficiency, but its my belief the "first decision" should
come from the PMC.